Annex II
United Kingdom
REJECTED HEALTH CLAIMS
| Application – Relevant provisions of Regulation (EC) No 1924/2006 | Nutrient, substance, food or food category | Claim | EFSA opinion reference |
|---|---|---|---|
| Article 14(1)(a) health claim referring to reduction of disease risk | NeOpuntia® | NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol | EFSA-Q-2008-214 |
| Article 14(1)(a) health claim referring to reduction of disease risk | Lactobacillus helveticus fermented Evolus®low-fat milk products | Evolus® reduces arterial stiffness | EFSA-Q-2008-218 |
| Article 14(1)(b) health claim referring to children’s development and health | regulat®.pro.kid IMMUN | regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth | EFSA-Q-2008-082 |
| Article 14(1)(b) health claim referring to children’s development and health | Dairy products | Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence | EFSA-Q-2008-110 |
| Article 14(1)(b) health claim referring to children’s development and health | Dairy products | Dairy foods (milk & cheese) promote dental health in children | EFSA-Q-2008-112 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) | DHA and ARA support neural development of the brain and eyes | EFSA-Q-2008-120 |
| Article 14(1)(b) health claim referring to children’s development and health | regulat®.pro.kid BRAIN | regulat®.pro.kid BRAIN contributes to mental and cognitive development of children | EFSA-Q-2008-083 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Calming | EFSA-Q-2008-091 and EFSA-Q-2008-096 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Provide serenity and room for a beneficial development of the child | EFSA-Q-2008-092 and EFSA-Q-2008-097 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Help to support vision | EFSA-Q-2008-095 and EFSA-Q-2008-100 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Help to support mental development | EFSA-Q-2008-098 and EFSA-Q-2008-104 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Help to promote concentration | EFSA-Q-2008-094 and EFSA-Q-2008-099 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Helps to promote the thinking capacity | EFSA-Q-2008-093 and EFSA-Q-2008-101 |
| Article 14(1)(b) health claim referring to children’s development and health | Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) | Help to support the learning ability | EFSA-Q-2008-102 and EFSA-Q-2008-103 |